NCT00795665 2020-05-12
Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma
University of California, Davis
Phase 2 Completed
University of California, Davis
Radiation Therapy Oncology Group
Duke University
Isarna Therapeutics GmbH